Skip to main content
. 2022 Nov 26;14(23):5836. doi: 10.3390/cancers14235836

Figure 10.

Figure 10

Bioluminescence imaging can be used to measure longitudinal responses. (A,B), Example of bioluminescence signal at E10, E12 and E14 monitoring ex ovo growth of an untreated MESO-8T tumour nodule. (C) Proposed experimental timeline for BLI imaging to evaluate xenografts pre- and post-dosing. (D,E) Comparison of bioluminescence signal for in ovo MSTO-211H tumour nodules at E10 and E14, following two yolk sac injections of PBS at E10 and E12 (n = 8).